As Pricing Scrutiny Turns To Physician-Administered Drugs, PhRMA Points To Supply Chain Culprits

 
• By Cathy Kelly
  
Physician-Administered Drugs A Fast Growing Health Care Cost

More from Pricing Debate

More from Market Access